HLA-B*15:21 carrier status is a susceptibility factor of carbamazepine-induced nonimmediate cutaneous adverse reactions in HLA-B*15:02-negative patients: A retrospective cohort study.

Ruanglertboon W, Seree-Aphinan C, Sangiemchoey A, Kaewpiboon K, Maneerot T, Plong-On O, Sangmanee P, Nichanon P, Khayman J, Manee J, Hnoonual A, Jaruthamsophon K

Open source

DOI
10.1002/bcp.70714
Published
2026 Jul 26
Container
British journal of clinical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/bcp.70714,
  title = {HLA-B*15:21 carrier status is a susceptibility factor of carbamazepine-induced nonimmediate cutaneous adverse reactions in HLA-B*15:02-negative patients: A retrospective cohort study.},
  author = {Ruanglertboon W and Seree-Aphinan C and Sangiemchoey A and Kaewpiboon K and Maneerot T and Plong-On O and Sangmanee P and Nichanon P and Khayman J and Manee J and Hnoonual A and Jaruthamsophon K},
  year = {2026},
  journal = {British journal of clinical pharmacology},
  doi = {10.1002/bcp.70714},
  url = {https://doi.org/10.1002/bcp.70714}
}

RIS

TY  - JOUR
TI  - HLA-B*15:21 carrier status is a susceptibility factor of carbamazepine-induced nonimmediate cutaneous adverse reactions in HLA-B*15:02-negative patients: A retrospective cohort study.
AU  - Ruanglertboon W
AU  - Seree-Aphinan C
AU  - Sangiemchoey A
AU  - Kaewpiboon K
AU  - Maneerot T
AU  - Plong-On O
AU  - Sangmanee P
AU  - Nichanon P
AU  - Khayman J
AU  - Manee J
AU  - Hnoonual A
AU  - Jaruthamsophon K
PY  - 2026
JO  - British journal of clinical pharmacology
DO  - 10.1002/bcp.70714
UR  - https://doi.org/10.1002/bcp.70714
ER  - 

APA

W, R., C, S., A, S., K, K., T, M., O, P., P, S., P, N., J, K., J, M., A, H., & K, J. (2026). HLA-B*15:21 carrier status is a susceptibility factor of carbamazepine-induced nonimmediate cutaneous adverse reactions in HLA-B*15:02-negative patients: A retrospective cohort study.. British journal of clinical pharmacology. https://doi.org/10.1002/bcp.70714

Source records